1. Signaling Pathways
  2. Others
  3. Others

Others

 
Cat. No. Product Name Effect Purity Chemical Structure
  • HY-112794
    Topanol CA
    98.11%
    Topanol CA serves as an effective antioxidant and stabilizer for resins and light-colored rubber products.
    Topanol CA
  • HY-N3808
    (4α,11β,15β)-11,15-Dihydroxykaur-16-en-19-oic acid
    (4α,11β,15β)-11,15-Dihydroxykaur-16-en-19-oic acid is a compound isolated from the Tunisian Pulicaria laciniata (Coss.et Kral.) Thell. flowers.
    (4α,11β,15β)-11,15-Dihydroxykaur-16-en-19-oic acid
  • HY-165514
    Nafimidone
    Nafimidone is a stable and brain-penetrant antiepileptic compound Nafimidone shows effective anticonvulsant effects in kindled amygdaloid seizure model. However, The effective window of Nafimidone is narrow, and has obvious epileptogenic effects at high doses. Nafimidone can be used for the study of epilepsy.
    Nafimidone
  • HY-N0994
    1,6-Dioxaspiro[4.5]decane-2-methanol
    1,6-Dioxaspiro[4.5]decane-2-methanol (Compound 6) is a natural product which can be derived from Dacus oleae.
    1,6-Dioxaspiro[4.5]decane-2-methanol
  • HY-N16052
    Dechlorflavonin
    Dechlorflavonin is a flavone that can be isolated from Aspergillus candidus strain.
    Dechlorflavonin
  • HY-163531
    GPR41 modulator 2
    Agonist
    GPR41 modulator 2 (Compound 10bx) exhibits agonistic activity for G protein-coupled receptor (GPR41).
    GPR41 modulator 2
  • HY-W012185A
    (-)-Sparteine hydroiodide
    Control
    (-)-Sparteine hydroiodide is a natural alkaloid that can be isolated from beans.
    (-)-Sparteine hydroiodide
  • HY-163089
    Anticancer agent 176
    Anticancer agent 176 (Compoint 10α) is an anticancer agent. Anticancer agent 176 exhibits excellent in vitro cytotoxic activity against neuroblastoma with an IC50 value of 6.3 μM.
    Anticancer agent 176
  • HY-P1966
    Ac-IEVDID TFA
    Ac-IEVDID TFA is a short peptide sequence with Ac at the end.
    Ac-IEVDID TFA
  • HY-107947
    Fluphenazine enanthate
    Fluphenazine enanthate is a long-acting injectable (LAI) antipsychotic for the treatment of schizophrenia.
    Fluphenazine enanthate
  • HY-145766
    Anisole-piperazine-methanone-benzothiazole-p-methylpiperidine
    99.14%
    Anisole-piperazine-methanone-benzothiazole-p-methylpiperidine is an active compound.
    Anisole-piperazine-methanone-benzothiazole-p-methylpiperidine
  • HY-148456
    Anti-inflammatory agent 34
    98.13%
    Anti-inflammatory agent 34 (Compound IVf) is an orally active anti-inflammatory and analgesic agent.
    Anti-inflammatory agent 34
  • HY-N10345
    Glucobrassicanapin potassium
    Glucobrassicanapin (4-Pentenylglucosinolate) potassium is an aliphatic glucosinolate in vegetable crops of Brassica rapa.
    Glucobrassicanapin potassium
  • HY-N1607
    18-Nor-4,15-dihydroxyabieta-8,11,13-trien-7-one
    18-Nor-4,15-dihydroxyabieta-8,11,13-trien-7-one is a compound isolated from the buds of Pinus banksiana Lamb.
    18-Nor-4,15-dihydroxyabieta-8,11,13-trien-7-one
  • HY-106207
    Celivarone
    Celivarone (SSR149744C) is a orally active noniodinated benzofuran derivative with antiarrhythmic properties. Celivarone has the potential for atrial fibrillation and in ventricular arrhythmias research.
    Celivarone
  • HY-121856
    Flumizole
    Flumizole, a derivative of substituted 5,6-diaryl-2,3-dihydroimidazo[2,1-b]thiazoles, was synthesized and evaluated for its immunoregulatory and anti-inflammatory properties in animal models such as rat adjuvant-induced arthritis and mouse oxazolone-induced contact sensitivity assays. This compound class combines structural elements from flumizole and levamisole, aiming to enhance therapeutic efficacy. Symmetrically substituted 5,6-diaryl compounds with specific alkyl heteroatom or halogen substitutions showed optimal potency in the arthritis model. However, variations in activity were less consistent in the contact sensitivity assay. Flumizole and related compounds demonstrate potential as dual-action agents, targeting inflammation and immune modulation, offering promise for therapeutic development in immune-related disorders.
    Flumizole
  • HY-154800
    Anticancer agent 113
    Anticancer agent 113 is a compound with anticancer activity.
    Anticancer agent 113
  • HY-151629
    MRV03-069
    MRV03-069 (Compound 3) is a selective colibactin-activated peptidase (ClbP) inhibitor that blocks the genotoxic effect of Colibactin (HY-145930) on eukaryotic cells. MRV03-069 can be used in colorectal cancer research.
    MRV03-069
  • HY-168002
    MPO-IN-8
    MPO-IN-8 is an orally active myeloperoxidase (MPO) inhibitor. MPO-IN-8 can inhibit the generation of hypochlorous acid in neutrophils and the release of extracellular traps (NETosis). In mice with gouty arthritis, MPO-IN-8 can reduce swelling, lower peroxidase activity, and decrease IL-1β levels.
    MPO-IN-8
  • HY-168991
    Laporolimus
    Laporolimus is an immunosuppressant.
    Laporolimus
Cat. No. Product Name / Synonyms Application Reactivity